Figures & data
Table 1 Initiation of disease-modifying drugs (DMDs): patient and physician responses, by country
Physician question:
On average, how long following the diagnosis of MS do you usually start to actively treat a patient with pharmacotherapies/DMDs?
Patient question:
How long following your diagnosis did you start undergoing treatment for your MS?
Table 2 Summary of treatment interruptions and discontinuations: patient and physician responses, by country
Physician questions:
1. Approximately what percentage, if any, of all your treated MS patients take a treatment break?
2. Approximately what percentage, if any, of all your treated MS patients stop their treatment?
Patient questions:
1. Have you ever taken a break from your MS treatment, ie, where you have actively decided not to take your treatment as opposed to forgetting to take it and which could last 1 day or longer?
2. Have you ever stopped taking your MS treatment?
Figure 1 Main reasons why patients may take a break or stop their MS treatment, as rated by physicians.
Figure 2 Main reasons for taking a break or stopping their MS treatment, as rated by patients.
Table S1 Questions included in physicians’ questionnaire
Table S2 Questions included in patients’ questionnaire